Bioventus Inc - Ordinary Shares - Class A Forecast, price target & analysts
Bioventus Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation
Bioventus Inc - Ordinary Shares - Class A Classifications & Recommendation:
Bioventus Inc - Ordinary Shares - Class A Price Target
| Target Price | $15.30 |
| Price | $7.28 |
| Potential |
110.17%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Bioventus Inc - Ordinary Shares - Class A 2026 .
The average Bioventus Inc - Ordinary Shares - Class A target price is $15.30.
This is
110.17%
register free of charge
$15.75
116.35%
register free of charge
$14.14
94.23%
register free of charge
|
|
| A rating was issued by 8 analysts: 6 Analysts recommend Bioventus Inc - Ordinary Shares - Class A to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Bioventus Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of
110.17%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 573.28 | 570.93 |
| 11.89% | 0.41% | |
| EBITDA Margin | 5.63% | 19.58% |
| 184.14% | 247.84% | |
| Net Margin | -5.85% | 9.41% |
| 80.81% | 260.84% |
5 Analysts have issued a sales forecast Bioventus Inc - Ordinary Shares - Class A 2025 . The average Bioventus Inc - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Bioventus Inc - Ordinary Shares - Class A EBITDA forecast 2025. The average Bioventus Inc - Ordinary Shares - Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Bioventus Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Bioventus Inc - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.52 | 0.65 |
| 79.12% | 225.00% | |
| P/E | 11.20 | |
| EV/Sales | 1.61 |
5 Analysts have issued a Bioventus Inc - Ordinary Shares - Class A forecast for earnings per share. The average Bioventus Inc - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Bioventus Inc - Ordinary Shares - Class A...
Current Bioventus Inc - Ordinary Shares - Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Jul 07 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 17 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Dec 17 2024 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 06 2024 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | Sep 27 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Jul 07 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 17 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Dec 17 2024 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 06 2024 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
Sep 27 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
